Blog | Sep 3, 2019

Blue Prism Acknowledged by Constellation Research for Advancing RPA

Cr shortlist member badge Q3 2018

Constellation Research has just published its Q3 2019 ShortList™ for Robotic Process Automation (RPA), naming Blue Prism among one of its top solutions to consider. The ShortList is compiled from an independent analysis of numerous vendor and partner briefings as well as conversations with early adopters clients pursuing digital transformation initiatives using RPA technology.

“In our experience working on tens of thousands of vendor selections, we’ve learned that no two organizations have the same requirements. We cut through the clutter and marketing hype and present the top offerings in each of our coverage areas. These vendors have battle tested solutions that our analysts have vetted and approved,” said R “Ray” Wang, chairman and founder at Constellation Research.

To arrive at the ShortList for RPA, Constellation Principle Analyst Dion Hinchclliffe evaluated over 40 solutions categorized in the RPA market using the following criteria:

  • Attended and unattended features for AI operation
  • Server and cloud-based solutions
  • Data pooling and collection
  • Bot development
  • Control room operations
  • Reporting tools and analytics
  • Resilience
  • Macro or scripted automation
  • Templates and use cases for business process management
  • Plug-in architecture tools, frameworks and integration
  • Automation management features including IT and DevOps support
  • Product versus services focus
  • Input/output options

Constellation advises leaders on leveraging disruptive technologies to achieve business model transformation. Blue Prism and the other 8 vendors named to this Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share and internal research. The portfolio is frequently updated every six months with the rapidly changing market conditions.

Constellation Research does not endorse any solution or service named in its research.